Romark Laboratories received a warning letter from the FDA regarding its product Alinia (nitazoxanide). The FDA charged that the sales aid and oral statements for Alinia are false or misleading because they promote unapproved uses and broaden the indication for Alinia, make unsubstantiated superiority claims, omit and minimize the risks associated with Alinia and/or make misleading compliance claims.
Roche added a new component to its $14 million diabetes education campaign, which pairs healthcare practitioners with Roche staff. “Creative Coaching” helps healthcare professionals with “the art of patient engagement.” Roche manufactures the Accu-Chek line of blood glucose monitors. The professional education program, Behavior Change through Patient Engagement, is multifaceted and includes a website with online tools and information.
San Mateo, CA-based Epocrates unveiled an OTC drug module that will allow clinicians to access the latest information for hundreds of brand name OTC drugs right from their iPhone, BlackBerry, Palm or Windows device. The OTC drug module is already used by more than 625,000 in the US.
From the August 01, 2009 Issue of MM+M - Medical Marketing and Media
